- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 14.54M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 21.3M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 353.93K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $16.81M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$20.45M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$887K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $65.91M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $8.02M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $168.34M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $239.42M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $7.71M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $9.25M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $13.33M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $40.93M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $39.28M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $66.88M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $82.53M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $13.57M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $207.61M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $306.3M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$3.64 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$5.54 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$3.64 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$5.54 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $7.49M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.97M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$76.26M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$2.37M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.63M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$1.97M |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.86M |